NeuroTherapy Ventures: Catalyzing Neurologic Innovations

Henry W. Chesbrough

Discusses the impact of limited market size on epilepsy therapies and shows how an early-stage venture fund can catalyze faster development of new treatments.

Learning Objective

Illustrates potential market failures for new drug development in epilepsy market and shows novel organizational vehicle to commercialize greater innovation from epilepsy research.

Details

Pub Date: Feb 8, 2002

Discipline: Operations Management

Subjects: Corporate social responsibility, Innovation, Technology, Venture capital

Source: Harvard Business School

Product #: 602124-PDF-ENG

Teaching note: Not available

Industry: Biotechnology

Geography: United States

Length: 22 page(s)